ENDRA LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2665 USD | -3.02% |
|
-15.50% | -87.43% |
| 05-14 | Transcript : ENDRA Life Sciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Endra Life Sciences Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.03M | - | - | - | - | - | |
| 58.71B | - | |||||
| 41.31B | ||||||
| 39.2B | ||||||
| 27.4B | ||||||
| 26.55B |
